Inventor · Berkeley, CA, US

John Flanagan

26Patents
9h-index
43Co-inventors
75Inventor score

Filing activity: Dec 14, 1993 → Mar 21, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US8592362B2 Method to predict response to pharmacological chaperone treatment of diseases Physics 53 Active
US9095584B2 Method to predict response to pharmacological chaperone treatment of diseases Physics 50 Active
US9545397B2 Method to predict response to pharmacological chaperone treatment of diseases Physics 48 Active
US10813921B2 Method to predict response to pharmacological chaperone treatment of diseases Physics 37 Active
USRE48608E1 Method to predict response to pharmacological chaperone treatment of diseases General 35 Active
US5795734A EPH receptor ligands, and uses related thereto Chemistry; Metallurgy 23 Expired
US5789182A System for assaying binding to a heparin-binding growth factor receptor Physics 21 Expired
US9404100B2 High concentration alpha-glucosidase compositions for the treatment of Pompe disease Chemistry; Metallurgy 16 Active
US9303249B2 High concentration α-glucosidase compositions for the treatment of Pompe disease Chemistry; Metallurgy 14 Active
US6399326B1 Nucleic acids encoding neural/pancreatic receptor tyrosine phosphatase Chemistry; Metallurgy 9 Expired
US9744188B2 Methods of promoting neuronal outgrowth by gypican 2 that binds to receptor protein tyrosine phosphatase sigma Human Necessities 5 Active
US10046033B2 High concentration alpha-glucosidase compositions for the treatment of Pompe disease Chemistry; Metallurgy 4 Active
US10512677B2 High concentration alpha-glucosidase compositions for the treatment of pompe disease Chemistry; Metallurgy 4 Active
US7381708B2 Suppression of eIF5A1 expression by the use of antisense oligonucleotides for the prevention of retinal cell death in the glaucomatous eye Chemistry; Metallurgy 2 Expired
US11808772B2 Biomarker combinations to simultaneously evaluate non-alcoholic steatohepatitis and hepatic fibrosis status Physics 1 Active
US6268476A EPH receptor ligands, and uses related thereto Chemistry; Metallurgy 1 Expired
US12208095B2 Methods of treating breast cancer with tetrahydronaphthalene derivatives as estrogen receptor degraders Human Necessities 0 Active
US7662796B2 Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1 Chemistry; Metallurgy 0 Active
US6919313B2 Protein waving a PDZ and a RGS domain Physics 0 Expired
US6777536B1 EPH receptor ligands, and uses related thereto Chemistry; Metallurgy 0 Expired
US11439615B2 Lipoxin and lipoxin analogue mediated neuroprotection and treatments Human Necessities 0 Active
US5801000A Detection and isolation of receptors Emerging Cross-Sectional Technologies 0 Expired
US8242256B2 siRNA useful to supress expression of EIF-5A1 Chemistry; Metallurgy 0 Active
US5554499A Detection and isolation of ligands Emerging Cross-Sectional Technologies 0 Expired
US11278599B2 High concentration alpha-glucosidase compositions for the treatment of Pompe disease Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.